Establishment and characterization of cell lines derived from uterine malignant mixed mullerian tumor

Gynecologic Oncology

Volumn 66, Issue 3, 1997, Pages 464-474

  Yuan, Ying ^b   Kim, Woo Ho ^b   Han, Hye Seung ^b   Lee, Jae Ho ^b   Park, Hyun Sook ^b   Chung, June Key ^b   Kang, Soon Beom ^a   Park, Jae Gahb ^a  

^a Seoul National University College of Medicine   (South Korea)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN EXPRESSION; ARTICLE; CELL VIABILITY; DNA DETERMINATION; DNA FINGERPRINTING; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MISSENSE MUTATION; MIXED MULLERIAN TUMOR; PRIORITY JOURNAL; TUMOR CELL LINE;

EID: 0031239987     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1997.4802     Document Type: Article

References (40)

1. 1. Chuang JT, Van Velden DJ, Graham JB: Carcinosarcoma and mixed mesodermal tumor of the uterine corpus: review of 49 cases. Obstet Gynecol 35:769-780, 1970
2. 2. Williamson EO, Christopherson WM: Malignant mixed müllerian tumors of the uterus. Cancer 29:585-592, 1972
3. 3. Ober WB: Uterine sarcomas: histogenesis and taxonomy. Ann NY Acad Sci 75:568-585, 1959
4. 4. Norris HJ, Roth E, Taylor HB: Mesenchymal tumors of the uterus. II. Clinical and pathologic study of 31 mixed mesodermal tumors. Obstet Gynecol 28:57-63, 1966
5. 5. Norris HJ, Taylor HB: Mesenchymal tumors of the uterus. III. a clinical and pathologic study of 31 carcinosarcomas. Cancer 19:1459-1465, 1966
6. 6. Kempson RL, Bari W: Uterine sarcomas: classification, diagnosis, and prognosis. Hum Pathol 1:331-349, 1970
7. 7. Salazar OM, Bonfiglio TA, Patten SF, Keller BE, Feldstein M, Dunne ME, Rudolph J: Uterine sarcomas: natural history, treatment and prognosis. Cancer 42:1152-1160, 1978
8. 8. Spanos WJ, Wharton JT, Gomez L, Fletcher GH, Oswald MJ: Malignant mixed müllerian tumors of the uterus. Cancer 53:311-316, 1984
9. 9. Nielsen SN, Podratz KC, Scheithauer BW, OüBrien PC: Clinico-pathologic analysis of uterine malignant mixed müllerian tumors. Gynecol Oncol 34:372-378, 1989
10. 10. Ishiwata I, Ishiwata C, Nagayama T, Ishikawa H: Histogenesis and culture of human uterine carcinosarcoma. Cancer Res 41:1978-1983, 1981
11. 11. Harker WG, MacKintosh FR, Sikic BI: Development and characterization of a human sarcoma cell line, MES-SA, sensitive to multiple drugs. Cancer Res 43:4943-4950, 1983
12. 12. Ono I, Ishiwata I, Tashiro A, Mihara A, Nakaguchi T, Ito S, Tokita N, Nakajima S, Ishiwata C, Soma M, Ishikawa H: Establishment and characterization of two human mixed mesodermal tumor cell lines from the same patient. J Natl Cancer Inst 72:1241-1252, 1984
13. 13. Emoto M, Iwasaki H, Kikuchi M, Ishiguro M, Kubota T, Izumi H, Shirakawa K, Kaneko Y: Two cell lines established from mixed müllerian tumors of the uterus. Cancer 69:1759-1768, 1992
14. 14. Emoto M, Iwasaki H, Kikuchi M, Shirakawa K: Characteristics of cloned cells of mixed müllerian tumor of the human uterus. Cancer 71:3065-3075, 1993
15. 15. Gorai I, Doi C, Minaguchi H: Establishment and characterization of carcinosarcoma cell line of the human uterus. Cancer 71:775-786, 1993
16. 16. Brower M, Carney DN, Oie HK, Gazdar AF, Minna JD: Growth of cell lines and clinical specimens of human non-small-cell lung cancer in serum-free defined medium. Cancer Res 46:798-806, 1986
17. 17. Park JG, Oie HK, Sugarbaker PH, Henslee JG, Chen TR, Johnson BE, Gazdar AF: Characteristics of cell lines established from human colorectal carcinoma. Cancer Res 47:6710-6718, 1987
18. 18. Hay R, Caputo J, Chen TR, Macy M, McClintock P, Reid Y: Catalogue of Cell Lines and Hybridomas, 7th ed, American Type Culture Collection, Rockville, MD, 1992
19. 19. Freshney RI: Culture of Animal Cells, 2nd ed, AR Liss, New York, 1994
20. 20. Goding JM: Monoclonal Antibodies: Principles and Practice, 3rd ed, San Diego, Academic Press, 1996
21. 21. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual, 2nd ed, New York, Cold Spring Harbor Laboratory Press, 1989
22. 22. Honma M, Kataoka E, Ohnishi K, Ohno T, Takeuchi M, Nomura N, Mizusawa H: A new DNA-profiling system for cell-line identification for use in cell banks in Japan. In Vitro Cell Dev Biol 28A:24-28, 1991
23. 23. Nigro SJ, Baker SJ, Preisinger AC, Jessup JM, Hostetter R, Cleary K, Bigner SH, Davidson N, Baylin S, Devilee P, Glover T, Collins FS, Weston A, Modali R, Harris CC, Vogelstein B: Mutations in the p53 gene occur in diverse human tumor types. Nature 342:705-708, 1989
24. 24. Kang MS, Lee HJ, Lee JH, Ku JL, Lee KP, Kelley MJ, Won YJ, Kim ST, Park JG: Mutation of p53 gene in hepatocellular carcinoma cell lines with HBX DNA. Int J Cancer 67:1-5, 1996
25. 25. Orita M, Iwahana H, Kanazawz H, Sekiya T: Detection of polymorphism of human DNA by gel electrophoresis as single strand conformation polymorphism. Proc Natl Acad Sci USA 86:2766-2770, 1989
26. 26. Orita M, Suzuki Y, Sekiya T, Hayashi K: A rapid and sensitive detection of point mutations and genetic polymorphism using polymerase chain reaction. Genomics 5:874-879, 1987
27. 27. Enomoto T, Fujita M, Inoue M, Nomura T, Shroyer KR: Alteration of p53 tumor suppressor gene and activation of c-K-ras-2 protooncogene in endometrial adenocarcinoma from Colorado. Anat Pathol 103:224-230, 1995
28. 28. Williamson P, Elder PA, Shaw ME, Devlin J, Knowles MA: p16 (CDKN2) is a major deletion target at 9p21 in bladder cancer. Hum Mol Genet 4:1569-1577, 1995
29. 29. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W, Bell R, Rosenthal J, Hussey C, Tran T, McClure M, Frye C, Hattier T, Phelps R, Haugen-Strano A, Katcher H, Yakumo K, Gholami Z, Shaffer D, Stone S, Bayer S, Wray C, Bogden R, Dayananth P, Ward J, Tonin P, Narod S, Bristow PK, Noris FH, Helvering L, Morrison P, Rostec P, Lai M, Barrett JC, Lewis C, Neuhausen S, Cannon-Albright L, Goldgar D, Wiseman R, Kamb A, Skolnick MH: A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66-71, 1994
30. 30. Han HJ, Yuan Y, Ku JL, Oh JH, Won YJ, Kang KJ, Kim KY, Kim S, Kim CY, Kim J-P, Oh N-G, Lee KH, Choe KJ, Nakamura Y, Park JG: Germline mutations of hMLH1 and hMSH2 genes in Korean hereditary nonpolyposis colorectal cancer. J Natl Cancer Inst 88:1317-1319, 1996
31. 31. Han HJ, Yanagisawa A, Kalo Y, Park JG and Nakamura Y: Genetic instability in pancreatic cancer and poorly differentiated type of gastric cancer. Cancer Res 53:5087-5089, 1993
32. 32. Heinen CD, Richardson D, White R, Groden J: Microsatellite instability in colorectal adenocarcinoma cell lines that have full-length adenomatous polyposis coli protein. Cancer Res 55:4797-4799, 1995
33. 33. Sanger F, Nicklen S, Coulson AR: DNA sequencing with chain terminating inhibitors. Proc Natl Acad Sci USA 74:5463-5466, 1977
34. 34. Meyer R: Mischgeschwülste des uterus: die komplizierten tumoren, in Henke F, Lubarsch O (eds): Handbuch der speziellen pathologischen anatomic und histologie. Berlin, Springer, 1930, Vol 7, pp 412-415
35. 35. Chung MT, Mukai K, Teshima S, Kishi K, Shimosato Y: Expression of various antigens by different components of uterine mixed müllerian tumors: an immunohistochemical study. Acta Pathol Jpn 38:35-45, 1988
36. 36. Geisinger KR, Dabbs DJ, Marshall RB: Malignant mixed müllerian tumors: an ultrastructural and immunohistochemical analysis with histogenetic considerations. Cancer 59:1781-1790, 1987
37. 37. Swisher EM, Gown AM, Skelly M, Ek M, Tamimi HK, Cain JM, Greer BE, Muntz HG, Goff BA: The expression of epidermal growth factor receptor, HER-2/neu, p53, and Ki-67 antigen in uterine malignant mixed mesodermal tumors and adenosarcoma. Gynecol Oncol 60:81-88, 1996
38. 38. Liu FS, Kohler MF, Marks JR, Bast RC, Boyd J, Berchuck A: Mutations and overexpression of the p53 tumor suppressor gene frequently occurs in uterine and ovarian sarcomas. Obstet Gynecol 83:118-124, 1994
39. 39. Greenblatt MS, Bennett WP, Hollstein M, Harris CC: Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54:4855-4878, 1994
40. 40. Berchuck A, Kohler MF, Marks JR, Wiseman R, Boyd J, Bast RC: The p53 tumor suppressor gene frequently is altered in gynecologic cancers. Am J Obstet Gynecol 170:246-252, 1994